Testing effectiveness (Phase 2)Study completedNCT02441686
What this trial is testing
Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma
Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 46